Comparing Pregnancy Outcomes After UAE and Laparoscopic Myomectomy in Women with Fibromyomata

OBGYN Library Team
Jul 18
3 min read

Fibromyomata, commonly known as uterine fibroids, affect many women of reproductive age and can impact fertility and pregnancy outcomes. When treatment is necessary, two common options are uterine artery embolization (UAE) and laparoscopic myomectomy. Each approach has distinct effects on the uterus and potential implications for future pregnancies. Understanding these differences is crucial for women who wish to conceive after treatment.

This article explores the pregnancy outcomes following UAE and laparoscopic myomectomy, focusing on key risks such as preterm delivery and malpresentation. It also discusses how recent observational studies inform patient counseling and decision-making.

Understanding Fibromyomata and Treatment Options

Fibromyomata are benign smooth muscle tumors of the uterus. They can cause symptoms like heavy menstrual bleeding, pelvic pain, and reproductive challenges. For women desiring pregnancy, treatment aims to relieve symptoms while preserving or improving fertility.

Uterine Artery Embolization (UAE)

UAE is a minimally invasive procedure that blocks blood flow to fibroids, causing them to shrink. It involves injecting embolic agents into the uterine arteries via a catheter. UAE avoids surgery but alters uterine blood supply, which may affect the uterine environment.

Laparoscopic Myomectomy

Laparoscopic myomectomy is a surgical procedure that removes fibroids while preserving the uterus. It uses small incisions and specialized instruments, offering a less invasive alternative to open surgery. This method physically removes fibroids but involves uterine incisions that require healing.

Pregnancy Outcomes After UAE and Laparoscopic Myomectomy

Recent observational studies have compared pregnancy outcomes after these treatments to guide women and clinicians in choosing the best approach.

Increased Risks After UAE

Research shows that pregnancies following UAE carry higher risks of certain complications:

Preterm Delivery: Women who conceive after UAE have a greater chance of delivering before 37 weeks. Preterm birth can lead to neonatal complications and long-term health issues.
Malpresentation: The position of the fetus at delivery is more likely to be abnormal (e.g., breech) after UAE. Malpresentation often necessitates cesarean delivery and can complicate labor.

These risks likely relate to changes in uterine blood flow and tissue integrity caused by embolization.

Outcomes After Laparoscopic Myomectomy

Pregnancies after laparoscopic myomectomy generally show more favorable outcomes:

Lower rates of preterm birth compared to UAE.
Reduced incidence of malpresentation.
Preservation of uterine structure supports normal fetal growth and positioning.

However, surgical risks such as uterine rupture during pregnancy, although rare, require careful monitoring.

Implications for Women Desiring Future Fertility

Choosing between UAE and laparoscopic myomectomy depends on multiple factors, including symptom severity, fibroid size and location, and reproductive goals.

For women prioritizing pregnancy, laparoscopic myomectomy may offer better chances of a healthy pregnancy with fewer complications.
UAE may be suitable for women who want symptom relief but do not plan future pregnancies or accept higher pregnancy risks.
Counseling should emphasize the increased risks of preterm delivery and malpresentation after UAE, helping women make informed decisions.

Counseling Based on Observational Study Findings

Observational studies provide valuable real-world data but have limitations such as potential selection bias and lack of randomization. Despite this, their findings highlight important trends:

Women should be informed about the higher likelihood of preterm birth and malpresentation after UAE.
Discussions should include the potential need for cesarean delivery and neonatal care in pregnancies after UAE.
For laparoscopic myomectomy, patients should understand the surgical risks and recovery time, balanced against improved pregnancy outcomes.
Shared decision-making is essential, incorporating patient preferences, clinical factors, and available evidence.

Practical Considerations for Patients and Providers

Pre-treatment evaluation should include detailed imaging to assess fibroid characteristics and uterine anatomy.
Fertility counseling must address the impact of each treatment on pregnancy risks.
Close pregnancy monitoring is recommended after either treatment, with particular attention to signs of preterm labor and fetal position.
Multidisciplinary care involving gynecologists, maternal-fetal medicine specialists, and radiologists can optimize outcomes.

Pregnancy after fibroid treatment requires careful planning and informed choices. Laparoscopic myomectomy generally offers safer pregnancy outcomes compared to UAE, especially for women aiming to conceive. Understanding the increased risks of preterm delivery and malpresentation after UAE helps women and clinicians weigh options carefully.

Women facing fibroid treatment should discuss their reproductive goals openly with their healthcare providers. This ensures personalized care that supports both symptom relief and healthy pregnancies.

Disclaimer: This article provides informational content based on current research and is not a substitute for professional medical advice. Patients should consult their healthcare providers for personalized recommendations.

REFERENCE:

Pregnancy outcomes after treatment for fibromyomata: Uterine artery embolization versus laparoscopic myomectomy18

Jay Goldberg, MD, Leonardo Pereira, MD, Vincenzo Berghella, MD, James Diamond, PhD, Emile Daraï, MD, Piero Seinera, MD, Renato Seracchioli, MD

Philadelphia, Pa, Paris, France, Turin and Bologna, Italy